We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Last July, a protester holds up a sign in front of the Federal Courthouse in Downtown Los Angeles to protest the loss of nation wide reproductive rights. Raquel Natalicchio via PA
Roe Vs Wade

US expands access to abortion pills through pharmacies

A doctor’s prescription will be needed to obtain the pills.

RETAIL PHARMACIES IN the United States will be permitted to sell abortion pills, a move that could significantly expand access to the procedure after last year’s landmark Supreme Court ruling that overturned federal abortion rights.

Regulatory changes announced by the Food and Drug Administration mean that mifepristone, which is the first of two drugs used to terminate a pregnancy, will be available in local drug stores in states where abortion is permitted.

A doctor’s prescription will be needed to obtain the pills, which were previously only available from a few mail-order pharmacies or certified doctors and clinics.

Demand for abortion pills has risen since the conservative-dominated Supreme Court made a landmark ruling last June that overturned Roe v. Wade, a 1973 case that had guaranteed women’s right to an abortion for half a century.

Abortion pills are already used in more than half of US procedures to terminate a pregnancy, experts say, and they have increasingly become a focus in the political and legal battle for abortion rights since the Supreme Court’s controversial decision.

Pharmacies will need to receive certification to dispense the drug, while patients will need to complete a consent form.

The FDA’s decision was welcomed by the American Civil Liberties Union.

“We are happy the FDA has increased pharmacy access to this safe and effective medication, relieving one of the agency’s needless burdens on mifepristone patients,” said Julia Kaye of the ACLU’s Reproductive Freedom Project.

Marjorie Dannenfelser, president of the anti-abortion organization Susan B. Anthony List slammed the decision.

“The Biden administration has once again proved that it values abortion industry profits over women’s safety and unborn children’s lives,” Dannenfelser said in a statement.

Your Voice
Readers Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.

    Leave a commentcancel